Stay updated on BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial
Sign up to get notified when there's something new on the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page.

Latest updates to the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2; the previous revision tag was removed.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision: v3.4.1 is now displayed on the page, replacing the previous Revision: v3.4.0.SummaryDifference0.0%

- Check27 days agoChange DetectedA glossary toggle labeled 'Show glossary' was added and a new revision tag 'Revision: v3.4.0' is displayed. The status lines now read 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', replacing the previous lowercase variants.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section updated to include site listings in Sioux Falls, South Dakota and Ontario (Ottawa and Toronto). The page revision is updated to v3.3.3.SummaryDifference0.3%

- Check92 days agoChange DetectedRevision: v3.3.2 appears on the page, replacing the previous v3.2.0 label. This is a minor UI update that does not affect the study details.SummaryDifference0.0%

Stay in the know with updates to BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page.